The Human IFN-alpha / IFN-alpha R Binding Assay Kit uses a rapid, simple, and sensitive method to characterize the binding affinity between IFN-alpha and its receptor IFN-alpha R in the presence of potential inhibitors within 4 hours. 4-8 week development phase.
Form:
96-well Microplate
Samples:
Plasma, Serum, Antibodies, Proteins, Small Molecules, Peptides
Target:
IFN-alpha (IFNA1), IFN-alpha R
Application Notes:
Colorimetric
* VAT and and shipping costs not included. Errors and price changes excepted